Inactive Instrument

Samsara Vision, Inc.

Equities

SMSA

US79600A1051

Medical Equipment, Supplies & Distribution

Samsara Vision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021

March 11, 2022 at 11:12 am

Samsara Vision, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was USD 0.039 million. Net loss was USD 8.18 million compared to USD 6.2 million a year ago.

Basic loss per share from continuing operations was USD 0.5515 compared to USD 0.4182 a year ago.

Latest news about Samsara Vision, Inc.

Samsara Vision Announces First U.S. Surgeries of the Sing Imt, for Age-Related Macular Degeneration as Part of the Concerto Study	11/07/22	CI
Samsara Vision and Lansheng Medical “Myvision” Announce Collaboration to Commercialize the Sing Imt™ in China	08/06/22	CI
Samsara Vision, Inc. to Initiate A U.S. Pma Supplemental Study of the Sing Imt™, A New-Generation Technology for Age-Related Macular Degeneration	20/04/22	CI
Samsara Vision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	11/03/22	CI
Samsara Vision, Inc. Auditor Raises 'Going Concern' Doubt	10/03/22	CI
Samsara Vision, Inc. Announces the First Three Successful Clinical Cases in Italy Using Its Sing Imt™	22/02/22	CI
Samsara Vision, Inc. has filed an IPO.	03/11/21	CI
Samsara Vision, Inc. Auditor Raises 'Going Concern' Doubt	30/09/21	CI
VisionCare Ophthalmic Technologies, Inc. Announces Appointment of Thierry Clidiere to Board of Directors	10/03/16	CI
VisionCare Ophthalmic Technologies Announces Executive Appointments	09/09/15	CI
Visioncare Ophthalmic Technologies Announces Executive Changes	15/04/15	CI
VisionCare Ophthalmic Technologies, Inc. announced that it has received funding	15/12/14	CI
VisionCare Ophthalmic Technologies, Inc. Announces Board Changes	15/04/14	CI
VisionCare Ophthalmic Technologies, Inc. Announces Management Promotions	28/03/14	CI
VisionCare Ophthalmic Technologies, Inc. Secures Up to $15 Million to Accelerate Growth of its Novel Treatment for Age-Related Macular Degeneration	17/09/13	CI
VisionCare Ophthalmic Technologies, Inc. announced that it has received $15 million in funding from Life Sciences Alternative Funding LLC.	17/09/13	CI
Visioncare Ophthalmic Technologies, Inc. Receives Health Canada Medical Device License for AMD Treatment	27/11/12	CI
VisionCare Ophthalmic Technologies, Inc. Receives Health Canada License for Telescope Prosthesis for End-Stage Macular Degeneration	08/11/12	CI
Florida Medicare Contractor Covers VisionCare Ophthalmic Technologies, Inc.'s Telescope Implant for End-Stage Macular Degeneration	09/10/12	CI
VisionCare Ophthalmic Technologies, Inc. Expands its CentraSight(TM) Provider Teams Nationwide	08/06/12	CI

Chart Samsara Vision, Inc.

Duration

Period

More charts

Company Profile

Samsara Vision, Inc is a specialty medical device company. The Company is involved in bringing vision and freedom back to patients suffering from late-stage conditions of the retina. It is engaged in the research, development, manufacturing, and marketing of ophthalmic devices and technologies that are intended to improve vision and quality of life for individuals with untreatable retinal disorders, particularly Age-Related Macular Degeneration (AMD). Its product line consists of its first-generation implantable miniature telescope (IMT), which it refers to as WA IMT; its Smaller-Incision, New Generation (SING) IMT, which it refers to as SING IMT; and its Tsert delivery system. Its WA IMT is the implantable medical device that works similarly to the telephoto lens of a camera, which enables improvement in vision and quality of life for individuals with the most advanced form of AMD, commonly referred to as late-stage AMD.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Medical Devices & Implants

	1st Jan change	Capi.
STRYKER CORPORATION	+15.20%	131B
SMITH & NEPHEW PLC	-7.27%	11.05B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-11.58%	7.71B
GLAUKOS CORPORATION	+41.65%	5.67B
INSPIRE MEDICAL SYSTEMS, INC.	-18.05%	4.95B
AXONICS, INC.	+7.99%	3.43B
ENOVIS CORPORATION	-19.96%	2.46B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-15.76%	1.97B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-16.68%	1.85B

Medical Devices & Implants